|
Volumn 275, Issue 49, 2000, Pages 38221-38229
|
A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIESTROGEN;
ANTISENSE OLIGONUCLEOTIDE;
CYCLIN D1;
CYCLIN E;
FULVESTRANT;
PROTEIN P130;
PROTEIN P21;
TRANSCRIPTION FACTOR E2F;
ARTICLE;
BREAST CANCER;
CANCER CELL;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE S PHASE;
CONTROLLED STUDY;
DRUG INHIBITION;
DRUG PROTEIN BINDING;
GENE ACTIVITY;
GENE EXPRESSION;
GENE INACTIVATION;
HUMAN;
HUMAN CELL;
MITOSIS INHIBITION;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
BREAST NEOPLASMS;
CDC2-CDC28 KINASES;
CELL CYCLE;
CELL DIVISION;
CYCLIN D1;
CYCLIN E;
CYCLIN-DEPENDENT KINASE 2;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLIN-DEPENDENT KINASES;
CYCLINS;
DNA-BINDING PROTEINS;
E2F4 TRANSCRIPTION FACTOR;
ENZYME INHIBITORS;
ESTRADIOL;
ESTROGEN ANTAGONISTS;
FEMALE;
G0 PHASE;
HUMANS;
KINETICS;
MODELS, BIOLOGICAL;
OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;
PHOSPHOPROTEINS;
PROTEIN-SERINE-THREONINE KINASES;
PROTEINS;
RETINOBLASTOMA-LIKE PROTEIN P130;
TRANSCRIPTION FACTORS;
TUMOR CELLS, CULTURED;
MINK CELL FOCUS-FORMING VIRUS;
|
EID: 0034623995
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M004424200 Document Type: Article |
Times cited : (125)
|
References (58)
|